EUVIMEDEUVIMED entdecken
Crossref

Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics

Emilie Rondinaud iD, Olivier Clermont, Marie Petitjean, Etienne Ruppé, Marina Esposito-Farèse, Anissa Nazimoudine, VOYAG-R Study Group, Bruno Coignard, Sophie Matheron, Antoine Andremont, Erick Denamur, Laurence Armand-Lefevre

Journal of Travel Medicine · 2023

DOI: 10.1093/jtm/taac141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Travel Medicine, 2023. Verfasst von Emilie Rondinaud und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriology Laboratory, Bichat-Claude Bernard Hospital, AP-HP Nord-Université Paris Cité, F-75018 Paris, France. Hauptthemen laut MEDLINE: Colistin, Escherichia coli Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colistin is an antibiotic of last resort in the management of highly drug-resistant Enterobacterales infections. Travel to some destinations presents a high risk of acquiring multidrug-resistant Enterobacterales, but little data are available on the risk of acquiring colistin-resistant strains. Here, we use the VOYAG-R sample collection (2012–2013) in order to evaluate the rate of acquisition of colistin-resistant Enterobacterales, excluding species with intrinsic resistance (CRE), following travel to tropical regions.

Methods

A total of 574 frozen stool samples of travellers returning from tropical regions were screened for colistin-resistant strains using ChromID Colistin R agar (bioMerieux®) after pre-enrichment culture with 1 mg/L of colistin. Genomes were obtained by Illumina sequencing and genetic determinants of colistin resistance (mutational events and mcr genes) were searched.

Results

A total of 22 travellers (3.8%) acquired colistin-resistant Enterobacterales carrying an mcr gene. Acquisition rates varied between visited regions: 9.2% (18/195) for Asia (southeast Asia: 17/18), 2.2% (4/184) for Latin America (Peru: 4/4) and 0% from Africa (0/195). Acquired strains were predominantly Escherichia coli (92%) and carried mostly the mcr-1 variant (83%). Escherichia coli strains belonged mainly to commensal phylogroups A and B1, and were genetically highly diverse (5 non-clonal sequence type (ST)10 and 17 ST singletons). Only four non mcr colistin-resistant strains (two E. coli and two Enterobacter cloacae complex) were identified. Among all the strains, two also carried extended-spectrum beta-lactamase genes.

Conclusions

Travel to tropical regions, and particularly to Southeast Asia, is a risk factor for the acquisition of mcr-carrying Enterobacterales. This study highlights the community dissemination of mcr in humans as early as 2012, 4 years prior to its first published description.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinEscherichia coli ProteinsHumansEscherichia coliDrug Resistance, BacterialAnti-Bacterial AgentsMicrobial Sensitivity Testsbeta-Lactamases

Stichwörter der Autor:innen

Escherichia coliMultidrug-resistantantibioticscommunitysoutheast Asiatravellerswhole genome sequencing

Substanzen

ColistinEscherichia coli ProteinsAnti-Bacterial Agentsbeta-LactamasesMCR-1 protein, E coli

Autor:innen und Institutionen

  • Bacteriology Laboratory, Bichat-Claude Bernard Hospital, AP-HP Nord-Université Paris Cité, F-75018 Paris, France.
  • University of Paris Cité, INSERM UMR 1137 IAME, F-75018 Paris, France.
  • URC HUPNVS, Paris, France; INSERM CIC 1425-EC, UMR1123, Clinical Investigation Center, Bichat-Claude Bernard Hospital, AP-HP Nord-Université Paris Cité, F-75018 Paris, France.
  • Public Health France, F-94415 Saint-Maurice, France.
  • Department of Infectious and Tropical Diseases, Bichat-Claude Bernard Hospital, AP-HP Nord-Paris Cité University, F-75018 Paris, France.
  • Molecular Genetics Laboratory, Bichat-Claude Bernard Hospital, AP-HP Nord-Université Paris Cité, F-75018 Paris, France.

ORCID-Profile: Emilie Rondinaud

Zitieren

APA

Rondinaud, E., Clermont, O., Petitjean, M., Ruppé, E., Esposito-Farèse, M., Nazimoudine, A., VOYAG-R Study Group, Coignard, B., Matheron, S., Andremont, A., Denamur, E., & Armand-Lefevre, L. (2023). Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taac141

Vancouver

Rondinaud E, Clermont O, Petitjean M, Ruppé E, Esposito-Farèse M, Nazimoudine A, et al. Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics. Journal of Travel Medicine. 2023. doi:10.1093/jtm/taac141

BibTeX
@article{Rondinaud2023,
  author = {Rondinaud, Emilie and Clermont, Olivier and Petitjean, Marie and Ruppé, Etienne and Esposito-Farèse, Marina and Nazimoudine, Anissa and VOYAG-R Study Group, VOYAG-R Study Group and Coignard, Bruno and Matheron, Sophie and Andremont, Antoine and Denamur, Erick and Armand-Lefevre, Laurence},
  title = {Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics},
  journal = {Journal of Travel Medicine},
  year = {2023},
  doi = {10.1093/jtm/taac141}
}
Kostenlos starten →